References: Billingsley, M
There is no clinical benefit to rushing through dose increases if your body hasn't adapted to the current dose
5.1 Limitations Most of the studies yet performed regarding SID and SIH employed observational designs, and data derived from randomised controlled clinical studies are lacking
Those rough weeks were absolutely worth it. -Sarah M., 42, Phase 3 trial participant What Are the Most Common Retatrutide Side Effects
A prospective study found (189) that 1 year after bariatric surgery, NASH was eliminated in 85% of patients, indicating that weight loss was closely related to the histological improvement of fatty liver
The goal is to make eating on a GLP-1 simple, enjoyable and sustainable while meeting your bodys needs and supporting weight loss